Authors:
Hesham Aboelkhir
1
;
Yousra El Alaoui
1
;
Regina Padmanabhan
1
;
Adel Elomri
1
;
Halima El Omri
2
and
Abdelfatteh El Oomri
3
Affiliations:
1
College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar
;
2
National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
;
3
Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar
Keyword(s):
Leukemia, Healthcare Expenditures, GCC, Global Figures, Clinical Burden.
Abstract:
Cancer constitutes a substantial global health challenge, which is poised to intensify primarily due to the growing elderly population globally. Leukemia, being a type of hematological cancer, presents unique diagnostic complexities compared to solid cancers, contributing to elevated levels of morbidity and mortality across various regions worldwide, resulting in a substantial clinical burden. Employing data sourced from the WHO Global Health Expenditure Database and the Institute for Health Metrics and Evaluation (IHME) Global Burden of Disease for the year 2019, this study undertakes an analysis of the prevalence, Years of Life Lost (YLLs), Years Lived with Disability (YLDs), Disability-Adjusted Life Years (DALYs), and healthcare expenditure in Gulf Cooperation Council (GCC) nations in comparison to the global figures.